Primary Breast Cancer Occurring Concomitant With Pregnancy

• Status: Completed
• Trial end date: 2020-07-08
• Target enrollment: 0
• Participant gender: Female

Summary

The goal of this clinical research study is to learn the results of multimodality (chemotherapy, surgery and radiation therapy) treatment of primary breast cancer that occurs at the same time as pregnancy. Researchers want to evaluate the outcome of labor and delivery as well as evaluate the long-term health outcomes of children exposed to chemotherapy while in their mother's womb.

• Phase: Early Phase 1
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: M.D. Anderson Cancer Center
• Treatments: Cyclophosphamide; Doxorubicin; Fluorouracil; Liposomal doxorubicin

Criteria

Inclusion Criteria:

· All patients with primary breast cancer occurring during pregnancy will be eligible for enrollment.

Exclusion Criteria:

• Patients presenting with systemic metastases at time of diagnosis.

• Patients unwilling or unable to give informed consent.

• Patients who have received radiation therapy while pregnant

• Patients who have received chemotherapy during the first trimester of pregnancy or chemotherapy other than FAC.